Component

ADOS-2 assessment score

ADOS-2 assessment score. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The study found no significant clinical improvement on ADOS-2, ABC or SRS-2 in the younger-child cohort.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/sulforaphane-research/36771424.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e", "start_char": 0, "end_char": 1410, "text_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e"}
    experimental_model
    Prospective randomized double-blind placebo-controlled study
    exposure
    Assessments at baseline, 18 and 36 weeks
    limitations
    Small sample with attrition; different age/formulation/endpoint context is retained rather than automatically classified as a contradiction.
    nutrient_topic
    Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
    organism
    Human, children aged 3-7; 40 randomized and 28 completed
    plain_language
    Later testing did not reproduce a clear benefit in this population.
    primary_references
    [sulforaphane-p36771424] Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study. (2023). https://pubmed.ncbi.nlm.nih.gov/36771424/ DOI: 10.3390/nu15030718
    tissue_or_cell_type
    ABC, SRS-2 and ADOS-2

    Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1386–1397

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Prospective randomized double-blind placebo-controlled study · source_derived_draft · unverified_draft

    ### sulforaphane-autism-younger-null The study found no significant clinical improvement on ADOS-2, ABC or SRS-2 in the younger-child cohort. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Later testing did not reproduce a clear benefit in this population. organism: Human, children aged 3-7; 40 randomized and 28 completed tissue_or_cell_type: ABC, SRS-2 and ADOS-2 experimental_model: Prospective randomized double-blind placebo-controlled study limitations: Small sample with attrition; different age/formulation/endpoint context is retained rather than automatically classified as a contradiction. exposure: Assessments at baseline, 18 and 36 weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/36771424.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e", "start_char": 0, "end_char": 1410, "text_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e"} [sulforaphane-p36771424] Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study. (2023). https://pubmed.ncbi.nlm.nih.gov/36771424/ DOI: 10.3390/nu15030718
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards